Labiana Health S.A [LAB] vs Almirall S.A [ALM] Detailed Stock Comparison

Labiana Health S.A

BME

Almirall S.A

BME

TLDR: Quick Comparison Summary

Based on 20 vital metrics comparison: Labiana Health S.A wins in 9 metrics, Almirall S.A wins in 7 metrics, with 0 ties. Labiana Health S.A appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric	Labiana Health S.A	Almirall S.A	Better
P/E Ratio (TTM)	N/A	102.60	N/A
Price-to-Book Ratio	5.80	1.51	Almirall S.A
Debt-to-Equity Ratio	1,378.08	26.47	Almirall S.A
PEG Ratio	N/A	22.30	N/A
EV/EBITDA	20.19	12.55	Almirall S.A
Profit Margin (TTM)	0.38%	2.02%	Almirall S.A
Operating Margin (TTM)	3.32%	3.22%	Labiana Health S.A
EBITDA Margin (TTM)	3.32%	3.22%	Labiana Health S.A
Return on Equity	6.92%	1.45%	Labiana Health S.A
Return on Assets (TTM)	5.72%	1.56%	Labiana Health S.A
Free Cash Flow (TTM)	$-4.68M	$-664,000	Almirall S.A
Dividend Yield	N/A	1.67%	N/A
1-Year Return	25.81%	14.70%	Labiana Health S.A
Price-to-Sales Ratio (TTM)	0.41	2.09	Labiana Health S.A
Enterprise Value	$66.63M	$2.24B	Almirall S.A
EV/Revenue Ratio	1.14	2.13	Labiana Health S.A
Gross Profit Margin (TTM)	147.79%	91.07%	Labiana Health S.A
Revenue per Share (TTM)	N/A	$5	N/A
Earnings per Share (Diluted)	$-0.16	$0.10	Almirall S.A
Beta (Stock Volatility)	-0.44	0.32	Labiana Health S.A

Performance

Key Stats

Valuation

Financials

Short Interest

Dividends

Labiana Health S.A vs Almirall S.A Stock Performance Analysis

Loading Price Chart...

Performance Comparison

Short-term Returns

Stock	1D	1W	1M	3M	6M	YTD
Labiana Health S.A	1.04%	5.41%	16.77%	20.37%	34.48%	32.65%
Almirall S.A	0.59%	0.59%	-4.81%	3.10%	13.19%	22.91%

Long-term Returns

Stock	1Y	3Y	5Y	10Y	15Y	20Y
Labiana Health S.A	25.81%	6,400.00%	1,081.82%	387.50%	387.50%	387.50%
Almirall S.A	14.70%	4.89%	7.74%	-43.75%	42.86%	-31.42%

Performance Comparison

This comparison requires JavaScript for dynamic charts and real-time data. For complete performance analysis, visit the individual stock overview pages:

Labiana Health S.A (LAB): View Full Stock Overview

Almirall S.A (ALM): View Full Stock Overview

The individual stock overview pages contain detailed performance metrics, historical charts, financial data, and comparison tools that work without JavaScript.

Key Performance Metrics Available:

Daily, weekly, monthly, and yearly returns
52-week high and low prices
Market capitalization and valuation ratios
Financial health and profitability metrics
Dividend history and yield information

Performance & Financial Health Analysis: Labiana Health S.A vs Almirall S.A

Metric	LAB	ALM
Market Information
Market Cap i	€27.87M	€2.20B
Market Cap Category	Small cap	Large cap
10 Day Avg. Volume i	17,783	133,831
90 Day Avg. Volume i	8,556	102,185
Last Close	€3.90	€10.30
52 Week Range	€1.86 - €4.00	€8.03 - €11.50
% from 52W High	-2.50%	-10.43%
All-Time High	€3.96 (Jul 10, 2025)	€19.09 (Dec 28, 2015)
% from All-Time High	-1.52%	-46.05%
Growth Metrics
Quarterly Revenue Growth	0.04%	0.10%
Quarterly Earnings Growth	N/A	-0.38%
Financial Health
Profit Margin (TTM) i	0.00%	0.02%
Operating Margin (TTM) i	0.03%	0.03%
Return on Equity (TTM) i	0.07%	0.01%
Debt to Equity (MRQ) i	1,378.08	26.47
Cash & Liquidity
Book Value per Share (MRQ)	€0.67	€6.81
Cash per Share (MRQ)	€0.01	€1.51
Operating Cash Flow (TTM) i	€7.19M	€152.00M
Levered Free Cash Flow (TTM) i	€6.02M	€39.89M
Dividends
Last 12-Month Dividend Yield i	N/A	1.67%
Last 12-Month Dividend i	N/A	€0.18

Valuation & Enterprise Metrics Analysis: Labiana Health S.A vs Almirall S.A

Metric	LAB	ALM
Price Ratios
P/E Ratio (TTM) i	N/A	102.60
Forward P/E i	4.33	22.30
PEG Ratio i	N/A	22.30
Price to Sales (TTM) i	0.41	2.09
Price to Book (MRQ) i	5.80	1.51
Market Capitalization
Market Capitalization i	€27.87M	€2.20B
Enterprise Value i	€66.63M	€2.24B
Enterprise Value Metrics
Enterprise to Revenue i	1.14	2.13
Enterprise to EBITDA i	20.19	12.55
Risk & Other Metrics
Beta i	-0.44	0.32
Book Value per Share (MRQ) i	€0.67	€6.81

Financial Statements Comparison: Labiana Health S.A vs Almirall S.A

Financial Metrics

Loading Financial Charts...

Revenue

EBITDA

Shareholders Equity

Operating Margin

Free Cash Flow

Long Term Debt

Profit Margin

Current Ratio

Operating Cash Flow

Income Statement (MRQ)

Metric (MRQ)	LAB	ALM
Revenue/Sales i	€10.58M	€286.10M
Cost of Goods Sold i	€-5.06M	€94.20M
Gross Profit i	€15.63M	€191.90M
Research & Development i	N/A	€35.50M
Operating Income (EBIT) i	€9.07M	€34.20M
EBITDA i	€11.11M	€72.90M
Pre-Tax Income i	€7.05M	€35.80M
Income Tax i	€0	€14.20M
Net Income (Profit) i	€7.05M	€21.60M

Balance Sheet & Liquidity Metrics (MRQ)

Metric (MRQ)	LAB	ALM
Cash & Equivalents i	€2.52M	€374.40M
Total Current Assets i	€28.76M	€764.60M
Total Current Liabilities i	€35.06M	€334.70M
Long-Term Debt i	€18.19M	€341.50M
Total Shareholders Equity i	€6.91M	€1.50B
Retained Earnings i	€-8.94M	N/A
Property, Plant & Equipment i	€1.23M	N/A

Cash Flow Statement Comparison (MRQ)

Metric (MRQ)	LAB	ALM
Operating Cash Flow i	€-7.21M	€35.70M
Capital Expenditures i	€-397,000	N/A
Free Cash Flow i	€-2.17M	€12.20M
Debt Repayment i	€-232,000	N/A
Common Stock Repurchase i	N/A	N/A

Short Interest & Institutional Ownership Analysis

Metric	LAB	ALM
Shares Short i	N/A	N/A
Short Ratio i	N/A	N/A
Short % of Float i	N/A	N/A
Average Daily Volume (10 Day) i	17,783	133,831
Average Daily Volume (90 Day) i	8,556	102,185
Shares Outstanding i	7.22M	213.24M
Float Shares i	N/A	78.20M
% Held by Insiders i	0.72%	0.65%
% Held by Institutions i	0.00%	0.18%

Dividend Analysis & Yield Comparison: Labiana Health S.A vs Almirall S.A

Metric	LAB	ALM
Last 12-Month Dividend i	N/A	€0.18
Last 12-Month Dividend Yield i	N/A	1.67%
3-Year Avg Annual Dividend i	N/A	€0.18
3-Year Avg Dividend Yield i	N/A	1.97%
3-Year Total Dividends i	N/A	€0.54
Ex-Dividend Date	N/A	May 15, 2025

Labiana Health S.A [LAB] vs Almirall S.A [ALM] Detailed Stock Comparison